CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Insulin lispro

Last Updated: September 27, 2017
Result type: Reports
Project Number: SE0543-000
Product Line: Reimbursement Review

Generic Name: Insulin lispro

Brand Name: Admelog

Manufacturer: sanofi-aventis Canada Inc.

Indications: Diabetes mellitus, Type 1 & 2

Submission Type: Initial

Project Status: Cancelled

Anticipated Date: October 26, 2017

Biosimilar: Yes

Fee Schedule: Pending